The cancer drug pipeline is promising but challenges remain
The drug development pipeline for oncology therapeutic agents is robust, with hundreds of new treatments in development. Researchers are developing innovative targeted therapies, immunotherapies, and combination regimens intended to treat various cancer types more effectively than current standards of care. However, drug development is a complex process with many hurdles. In this article, we will analyze the current ... Read more
